NCT02243722

Brief Summary

Laryngeal motor and sensory nerve dysfunction may cause phonation and swallowing disturbance, which often happens after the treatment for laryngopharyngeal and esophageal cancer and may induce fatal complications such as aspiration pneumonia. By the conventional examinations, the tiny sensory or motor changes are hard to be detected before complete vocal paralysis. It is utmost important to establish a comprehensive quantitative method which is sensitive enough to evaluate the neuromuscular functions. The present project will evaluate the laryngeal nerve function by quantitative laryngeal electromyography, which was developed by the research team, and another novel examination technique, mucosal membrane sensation test. The comprehensive method is expected to grade the laryngeal nerve injuries quantitatively before the significant symptoms or complications and can also help to evaluate the treatment effect from medicine, rehabilitation or surgery.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jul 2014

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2014

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

September 16, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 18, 2014

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2016

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2016

Completed
Last Updated

September 18, 2014

Status Verified

February 1, 2014

Enrollment Period

2.1 years

First QC Date

September 16, 2014

Last Update Submit

September 16, 2014

Conditions

Keywords

laryngeal electromyographyintrinsic laryngeal musclesrecurrent laryngeal nervesuperior laryngeal nervelaryngeal sensationtone language

Outcome Measures

Primary Outcomes (2)

  • Fiberoptic endoscopic evaluation of swallowing (FEES)

    Swallowing evaluation

    Baseline:Within 3-6 months after synptom occurs

  • Laryngo-pharyngeal mucosa sensation test

    There were four probes of different diameters that similar to the Von Frey filament were prepared for the examination. The diameters were 0.07mm, 0.15mm.0.2 mm and 0.3 mm. The mono-filament nylon probe was placed and contact with the tip and arytenoid mucosa.

    Baseline:Within 3-6 months after synptom occurs

Secondary Outcomes (5)

  • laryngeal electromyography

    Baseline:Within 3-6 months after synptom occurs

  • laboratory voice analysis

    Baseline:Within 3-6 months after synptom occurs

  • voice range profile

    Baseline:Within 3-6 months after synptom occurs

  • Voice Handicap Index (VHI)

    Baseline:Within 3-6 months after synptom occurs

  • Disease related life quality assessment: FACT-H&N, FACT-E

    Baseline:Within 3-6 months after synptom occurs

Study Arms (1)

Larynx pharynx and Esophagus Ca with VCP

The cases of laryngopharyngeal and esophageal cancer with endoscopic characters of vocal fold motion impairment (paralysis or fixation)

Eligibility Criteria

Age20 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients from a tertian referral medical center.

You may qualify if:

  • Patients with laryngopharyngeal or esophageal cancer who have taken active therapy and are not neck tissue damage.
  • Patients with clear conscious and stable mental status

You may not qualify if:

  • Patients who cannot sit for longer than 30 minutes or received other vocal cord treatments before the selection
  • Pregnant and breastfeeding women
  • Patients with communication disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chang Gung Memorial Hospital

Taoyuan District, Taiwan

RECRUITING

MeSH Terms

Conditions

Vocal Cord Paralysis

Condition Hierarchy (Ancestors)

Laryngeal DiseasesRespiratory Tract DiseasesOtorhinolaryngologic DiseasesVagus Nerve DiseasesCranial Nerve DiseasesNervous System DiseasesParalysisNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Tuan-Jen Fang, MD

    Chang Gung Memorial Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Tuan-Jen Fang, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Target Duration
3 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 16, 2014

First Posted

September 18, 2014

Study Start

July 1, 2014

Primary Completion

August 1, 2016

Study Completion

November 1, 2016

Last Updated

September 18, 2014

Record last verified: 2014-02

Locations